We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601985:SSEChina National Nuclear Power Co. Ltd. Class A Analysis

Data as of 2026-06-13 - not real-time

CN¥9.24

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at CNY 9.24, just below the computed resistance of 9.37 and comfortably above the support of 8.66, with the 20‑day SMA (9.01) edging above the 50‑day SMA (8.97) and the 200‑day SMA (8.89), indicating a short‑term bullish alignment. Technical indicators reinforce this view: the RSI sits at 58.8 (neutral‑to‑bullish), the MACD histogram is positive (0.015) and the MACD signal is bullish, while volume is on an increasing trend, all suggesting upward momentum.
However, the fundamentals tell a more cautious story. Revenue has contracted by 6.6% YoY, free cash flow is deeply negative (‑CNY 57.6 bn), and the debt‑to‑equity ratio is extreme at 196.7, dwarfing the modest cash reserves. The PE ratio of 23.1 sits above the industry average of 20.5, and while the dividend yield of 1.95% and a 45% payout appear attractive, the sustainability is questionable given the cash‑flow deficit. The low beta (0.15) and regulated utility backdrop temper market volatility, but the high leverage and earnings pressure raise significant downside risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD and RSI above 50
  • Price trading near technical resistance
  • Increasing trading volume supporting momentum

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Revenue decline of 6.6% YoY
  • Extreme debt‑to‑equity ratio (≈197)
  • Negative free cash flow undermining dividend sustainability

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Regulated utility sector with low beta
  • State‑backed nuclear assets offering stable cash flows over time
  • Current valuation above industry peers limiting upside

Key Metrics & Analysis

Financial Health

Revenue Growth-6.60%
Profit Margin10.20%
P/E Ratio23.1
ROE7.02%
ROA2.35%
Debt/Equity196.72
P/B Ratio1.6
Op. Cash FlowCN¥39.8B
Free Cash FlowCN¥-57637261312
Industry P/E20.5

Technical Analysis

TrendBullish
RSI58.8
SupportCN¥8.66
ResistanceCN¥9.37
MA 20CN¥9.01
MA 50CN¥8.97
MA 200CN¥8.89
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

GradeOvervalued
TypeValue
Dividend Yield1.95%

Risk Assessment

Beta0.15
Volatility21.50%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.